RegulatorySpineTop Stories

Life Spine Announces FDA 510(k) Clearance for the ProLift® Micro Expandable Spacer System

October 12, 2021

HUNTLEY, Ill.–(BUSINESS WIRE)–Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) to market the ProLift micro Expandable Spacer System.

ProLift micro is uniquely designed to support Micro Invasive procedures ranging from endoscopic TLIFs to MIS TLIFs/PLIFs. ProLift micro features an 8mm width, self-locking expansion at any height (8mm to 16mm) to suit the patient’s individual pathology and anatomical conditions. In addition, ProLift micro is available in a range of sizes and footprints.

“ProLift micro is designed for a fully percutaneous fusion via an endoscopic approach. The procedure, which is being developed for next year, consists of fully integrated augmented reality (AR) and 3D imaging. The AR vision system allows the surgeon to view live endoscopic 3D video, interactive product images and pre-op/real time radiographs,” said Rich Mueller, Chief Operating Officer for Life Spine.

ProLift micro marks the company’s 14th expandable interbody device making it one of the largest and most innovative portfolios within the spine fusion market.

ProLift micro Features and Benefits:

  • Post-packable & Repositionable, in situ
  • Osseo-Loc® Surface Technology
  • Intuitive instrumentation that helps protect neural anatomy
  • 0˚, 7˚, 12˚, & 15˚ Lordosis
  • Augmented Reality Assisted Fusions – coming next year

About Life Spine

Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms. Life Spine, which is privately held, is based in Huntley, Illinois. For more information, please visit: and/or


Mr. Omar Faruqi
Chief Financial Officer

Image: Life Spine

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button